Patents by Inventor Hillel Glover

Hillel Glover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10987350
    Abstract: Disclosed and described is a novel dose titration procedure for administering the opioid antagonist, nalmefene, to a patient diagnosed with post-traumatic stress disorder (PTSD).
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: April 27, 2021
    Inventors: Hillel Glover, Lillian Hahn
  • Publication number: 20200197387
    Abstract: Disclosed and described is a novel dose titration procedure for administering the opioid antagonist, nalmefene, to a patient diagnosed with post-traumatic stress disorder (PTSD).
    Type: Application
    Filed: April 25, 2018
    Publication date: June 25, 2020
    Inventors: Hillel Glover, Elliot Hahn
  • Publication number: 20040242974
    Abstract: An antidepressant or a pharmaceutically acceptable salt thereof, and an opiate antagonist or a pharmaceutically acceptable salt thereof, are used to treat refractory depression characterized by dissociation.
    Type: Application
    Filed: June 29, 2004
    Publication date: December 2, 2004
    Inventor: Hillel Glover
  • Publication number: 20030087896
    Abstract: An antidepressant or a pharmaceutically acceptable salt thereof, and an opiate antagonist or a pharmaceutically acceptable salt thereof, are used to treat refractory depression characterized by dissociation.
    Type: Application
    Filed: August 9, 2001
    Publication date: May 8, 2003
    Inventor: Hillel Glover
  • Patent number: 5028612
    Abstract: An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions.
    Type: Grant
    Filed: March 22, 1990
    Date of Patent: July 2, 1991
    Inventor: Hillel Glover
  • Patent number: 5013740
    Abstract: An opiate antagonist or a pharmaceutically acceptable salt thereof is used to treat emotional numbness associated with Post Traumatic Stress Disorder and other psychopathologic conditions. Opiate antagonist or a pharmaceutically acceptable salt thereof is also used to treat coma.
    Type: Grant
    Filed: May 4, 1990
    Date of Patent: May 7, 1991
    Inventor: Hillel Glover